Inventor
SAUNDERS JEFFREY O
US64 patents
⚠️ This page may combine multiple inventors who share the name “SAUNDERS JEFFREY O”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VERTEX PHARMA
20 patentsUS6344465B1Feb 5, 2002
Inhibitors of IMPDH enzyme
VERTEX PHARMA186 citations99
US6054472AApr 25, 2000
Inhibitors of IMPDH enzyme
VERTEX PHARMA242 citations99
US5807876ASep 15, 1998
Inhibitors of IMPDH enzyme
VERTEX PHARMA304 citations99
US5516797AMay 14, 1996
Immunosuppressive compounds
VERTEX PHARMA121 citations99
US5330993AJul 19, 1994
Immunosuppressive compounds
VERTEX PHARMA143 citations99
US6541496B1Apr 1, 2003
Inhibitors of IMPDH enzyme
VERTEX PHARMA80 citations98
US5192773AMar 9, 1993
Immunosuppressive compounds
VERTEX PHARMA163 citations97
US5717092AFeb 10, 1998
Compounds with improved multi-drug resistance activity
VERTEX PHARMA54 citations96
US5620971AApr 15, 1997
Biologically active acylated amino acid derivatives
VERTEX PHARMA88 citations96
US6653309B1Nov 25, 2003
Inhibitors of IMPDH enzyme technical field of the invention
VERTEX PHARMA131 citations95
US5622970AApr 22, 1997
Immunosuppressive compounds
VERTEX PHARMA61 citations95
US5723459AMar 3, 1998
Biologically active acylated amino acid derivatives
VERTEX PHARMA28 citations92
US5932600AAug 3, 1999
Inhibitors of IMPDH enzyme
VERTEX PHARMA22 citations91
US7989498B2Aug 2, 2011
Inhibitors of IMPDH enzyme
VERTEX PHARMA19 citations90
US6518291B1Feb 11, 2003
Inhibitors of IMPDH enzyme
VERTEX PHARMA30 citations90
US6967214B2Nov 22, 2005
Inhibitors of IMPDH enzyme
VERTEX PHARMA12 citations84
US7432290B2Oct 7, 2008
Inhibitors of IMPDH enzyme
VERTEX PHARMA6 citations74
US7329681B2Feb 12, 2008
Inhibitors of IMPDH enzyme
VERTEX PHARMA8 citations74
US5935954AAug 10, 1999
Compounds with improved multi-drug resistance activity
VERTEX PHARMA9 citations74
US7485664B2Feb 3, 2009
Inhibitors of TACE
VERTEX PHARMA2 citations61
AGIOS PHARMACEUTICALS INC
15 patentsUS9512107B2Dec 6, 2016
Therapeutically active compositions and their methods of use
AGIOS PHARMACEUTICALS INC25 citations94
US9732062B2Aug 15, 2017
Therapeutically active compounds and their methods of use
AGIOS PHARMACEUTICALS INC18 citations92
US9656999B2May 23, 2017
Therapeutically active compounds and their methods of use
AGIOS PHARMACEUTICALS INC16 citations92
US10294215B2May 21, 2019
Therapeutically active compounds and their methods of use
AGIOS PHARMACEUTICALS INC6 citations84
US10029987B2Jul 24, 2018
Therapeutic compounds and compositions
AGIOS PHARMACEUTICALS INC9 citations84
US9458132B2Oct 4, 2016
Therapeutic compounds and compositions and their use as PKM2 modulators
AGIOS PHARMACEUTICALS INC18 citations84
US10610125B2Apr 7, 2020
Methods and compositions for cell-proliferation-related disorders
AGIOS PHARMACEUTICALS INC9 citations81
US11505538B1Nov 22, 2022
Therapeutically active compounds and their methods of use
AGIOS PHARMACEUTICALS INC1 citations73
US9657004B2May 23, 2017
Pyruvate kinase M2 modulators, therapeutic compositions and related methods of use
AGIOS PHARMACEUTICALS INC1 citations63
US12428376B2Sep 30, 2025
Therapeutic compounds and compositions
AGIOS PHARMACEUTICALS INC0 citations62
US11866411B2Jan 9, 2024
Therapeutic compounds and compositions
AGIOS PHARMACEUTICALS INC0 citations62
USRE49582EJul 18, 2023
Therapeutic compounds and compositions
AGIOS PHARMACEUTICALS INC0 citations62
US10988448B2Apr 27, 2021
Therapeutic compounds and compositions
AGIOS PHARMACEUTICALS INC0 citations62
US10202339B2Feb 12, 2019
Therapeutic compounds and compositions
AGIOS PHARMACEUTICALS INC1 citations62
US10011574B2Jul 3, 2018
Glutaminase inhibitors and method of use
AGIOS PHARMACEUTICALS INC1 citations62
SALITURO FRANCESCO G
6 patentsUS8742119B2Jun 3, 2014
Pyruvate kinase M2 modulators, therapeutic compositions and related methods of use
SALITURO FRANCESCO G39 citations98
US8785450B2Jul 22, 2014
Therapeutic compounds and compositions
SALITURO FRANCESCO G45 citations97
US9328077B2May 3, 2016
Bicyclic PKM2 activators
SALITURO FRANCESCO G21 citations92
US9221792B2Dec 29, 2015
N-(4-(azetidine-1-carbonyl) phenyl)-(hetero-) arylsulfonamide derivatives as pyruvate kinase M2 (PMK2) modulators
SALITURO FRANCESCO G17 citations84
US9199968B2Dec 1, 2015
Therapeutic compounds and compositions
SALITURO FRANCESCO G10 citations84
US8501953B2Aug 6, 2013
PKM2 modulators for use in the treatment of cancer
SALITURO FRANCESCO G19 citations84
SQUIBB & SONS INC
5 patentsUS5099035AMar 24, 1992
Mevinic acid derivatives useful as antihypercholesterolemic agents and method for preparing same
SQUIBB & SONS INC20 citations82
US5166364ANov 24, 1992
Mevinic acid derivatives useful as antihypercholesterolemic agents and method for preparing same
SQUIBB & SONS INC12 citations74
US5173487ADec 22, 1992
Mevinic acid derivatives
SQUIBB & SONS INC3 citations63
US5001148AMar 19, 1991
Mevinic acid derivatives
SQUIBB & SONS INC2 citations63
US5264455ANov 23, 1993
Sulfur-substituted mevinic acid derivatives
SQUIBB & SONS INC4 citations62
LEMIEUX RENE M
2 patents(unassigned)
1 patentELIXIR PHARMACEUTICALS INC
1 patentShowing the top 50 of 64 patents by PatentIndex Score.